)
)
Alexion Pharmaceuticals Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Alexion Pharmaceuticals Inc
Access all reports
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the development and commercialization of innovative therapies for patients with rare and severe disorders. Alexion’s core business is focused on serving individuals afflicted with ultra-rare disorders through commercializing high-quality products that are priced based on their value. Alexion Pharmaceuticals is a subsidiary of AstraZeneca, and an American pharmaceutical company headquartered in Boston, Massachusetts
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
ALXN
Country
🇺🇸 United States